X chromosome inactivation and genomic imprinting are classic epigenetic processes that cause disease when not appropriately regulated in mammals. Whereas X chromosome inactivation evolved to solve the problem of gene dosage, the purpose of genomic imprinting remains controversial. Nevertheless, the two phenomena are united by allelic control of large gene clusters, such that only one copy of a gene is expressed in every cell. Allelic regulation poses significant challenges because it requires coordinated long-range control in cis and stable propagation over time. Long noncoding RNAs have emerged as a common theme, and their contributions to diseases of imprinting and the X chromosome have become apparent.
Here, the authors review recent advances in basic biology, the connections to disease, and preview potential therapeutic strategies for future development.
- Lee JT, Bartolomei MS. (2013) X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 152(6), 1308-23. [abstract]